$CE·Mar 16, 2026 at 1:14 PM ET·On the fenceIs CE a Good Buy After Roche's Recent Approval?I’ve been keeping an eye on CE lately, especially after Roche received CE approval for their Elecsys ApoE4 biomarker test. This approval could be a significant catalyst for the co...